Center for Integrated and Novel Approaches in Vascular-Metabolic Disease
University Hospitals Harrington Heart & Vascular Institute has established the novel Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (UH CINEMA). UH CINEMA brings together multiple disciplines in a unique platform to advance the understanding and treatment of cardiac and vascular complications of metabolic disease. UH CINEMA leverages existing system resources and builds on years of collaborative experience among UH principal investigators and clinical care providers.
Make a Referral
For more information or to refer a patient, call 216-844-1357 orEmail CINEMA@UHhospitals.org.
The Need for Integrated Cardiometabolic Care
Proud Charter Member of
The highest quality care of patients with obesity and diabetes necessitates a multidisciplinary team approach and requires a far greater degree of collaboration than other diseases. The chronicity of these health problems, the complexity of diagnosis and treatment, and the traditional siloes of various specialists result in delayed, fragmented, and high-cost care delivery that begs for an alternate model. The treatment of cardiovascular complications of metabolic disorders typified by type 2 diabetes is at the top of healthcare spending and the heart of the near-term healthcare affordability crisis. One of the barriers has been the failure to intervene in early disease.
Second Annual CINEMA Symposium
The second annual CINEMA Symposium was held on June 8, 2023. Watch the event video featuring a roundtable discussion on the topic of harmonizing guidelines for patients with chronic kidney disease, type 2 diabetes and cardiovascular disease:
Watch Now
Inaugural CINEMA Symposium
The inaugural CINEMA Symposium was held on May 19, 2022. Watch the event video featuring the following topics:
- Update on Comprehensive Diabetes Care in 2022
- Cardiometabolic Center of Excellence: A Novel Model for Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes
- Impact of Current and Future Clinical Trials in Diabeto-Cardiology
CINEMA Symposium - Introduction
Update on Comprehensive Diabetes Care in 2022
Cardiometabolic Center of Excellence
Impact of Current and Future Clinical Trials
Panel DiscussionA New Approach
UH CINEMA’s focus is at the intersection of vascular disease, type 2 diabetes, and obesity. The major consequence of metabolic disorders is cardiovascular complications such as coronary, cerebrovascular, and peripheral artery disease, so these are necessarily a priority for the team. However, the center also focuses on cures for other rare metabolic diseases with vascular manifestations.
Referred patients have a single appointment health assessment to review questions about their metabolic condition (diabetes), along with screening for kidney disease, heart disease, and related risk factor management (blood pressure, cholesterol and triglycerides, smoking, diet and exercise). Multiple specialists then review the assessment and share combined treatment recommendations to lower the potential risk for diabetes-related heart and kidney complications.
New Program Helps Diabetes Patients Avoid Heart and Kidney Complications
Adults with diabetes are up to four times more likely to die from heart disease than adults without diabetes. Diabetes patients have a unique resource that combines care to support the best outcomes.
American Diabetes Association Highlights UH CINEMA
Program Helps Patients with Diabetes Avoid Heart and Kidney Complications
Cardiometabolic Risk Factors
Metabolic Risk Factors
Abdominal obesity
Diabetes mellitus
Hyperglycemia
Hypertriglyceridemia
Non-Traditional Cardiovascular Risk Factors
Genetic profile
Inflammatory disease
Prothrombotic state
Traditional Cardiovascular Risk Factors
Age and gender
Family history
Hyperlipidemia
Hypertension
Smoking
Patient Care
Learn how CINEMA cares for diabetic patient's cardiovascular and renal health using coordinated, comprehensive treatment plans.
Follow UH CINEMA on X
Download the UH Provider App
